About Lucid Diagnostics Inc
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.luciddx.com/
Frequently Asked Questions
What is the 52-week range for LUCD?
The 52-week high is $1.629 and the 52-week low is $0.5.
What is the P/E ratio for LUCD?
The P/E ratio data is currently unavailable.
What is the dividend yield for LUCD?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -404.34%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -959.76%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 13.07.
Analyst Recommendation Trends
Wall Street analyst consensus for LUCD over the last few months:
Latest LUCD News
What's going on in today's after hours session
After the conclusion of the US market's regular session on Thursday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Elutia (NASDAQ:ELUT) stock moved upwards by 17.2% to $0.94 during Thursday's after-market session. The market value of their outstanding shares is at $34.9 million. Intelligent Bio Solutions (NASDAQ:INBS)
Which stocks are experiencing notable movement on Thursday?
Wondering how the US markets performed in the middle of the day on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Nexalin Technology (NASDAQ:NXL) shares increased by 77.8% to $7.61 during Thursday's regular session. The company's market cap stands at $3.5 million. Stablecoin Development (AMEX:SDEV) stock rose
Lucid Diagnostics Advances Multiple EsoGuard® and EsoCheck® Payment, Billing and Coding Pathways
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced advances in multiple payment, billing, and coding pathways for its EsoGuard® Esophageal DNA Test and EsoCheck® Esophageal Cell Collection Device, following three public meetings held last week.
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers IM Cannabis (NASDAQ:IMCC) stock rose 108.5% to $3.63 during Friday's pre-market session. The market value of their outstanding shares is at $1.0 million. Alaunos Therapeutics (NASDAQ:TCRT) shares increased
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-05-20 | Matheis Dennis | +245,000 | $1.0011 | $245,270 |
| 2026-02-20 | Matheis Dennis | +123,000 | - | - |
| 2026-02-20 | White Debra | +123,000 | - | - |
| 2026-02-20 | O'Neil Shaun | +620,000 | - | - |
| 2026-02-20 | Gordon Michael Adam | +300,000 | - | - |
| 2026-02-20 | Lapidus Stanley | +123,000 | - | - |
| 2026-02-20 | Cox James L | +123,000 | - | - |
| 2026-02-20 | Sparks Ronald M | +123,000 | - | - |
| 2026-02-20 | Aklog Lishan | +2,170,000 | - | - |
| 2026-02-20 | SOKOLOV JACQUE J | +123,000 | - | - |
| 2026-02-20 | MCGRATH DENNIS M | +470,000 | - | - |
| 2026-02-20 | PALUMBO JOHN R | +123,000 | - | - |
| 2025-10-06 | PALUMBO JOHN R | +215,000 | - | - |